Salivary lactate and 8-isoprostaglandin F
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
04 05 2020
04 05 2020
Historique:
received:
30
10
2019
accepted:
03
04
2020
entrez:
6
5
2020
pubmed:
6
5
2020
medline:
7
1
2021
Statut:
epublish
Résumé
Heart failure (HF) is a cardiovascular disease affecting about 26 million people worldwide costing about $100 billons per year. HF activates several compensatory mechanisms and neurohormonal systems, so we hypothesized that the concomitant monitoring of a panel of potential biomarkers related to such conditions might help predicting HF evolution. Saliva analysis by point-of-care devices is expected to become an innovative and powerful monitoring approach since the chemical composition of saliva mirrors that of blood. The aims of this study were (i) to develop an innovative procedure combining MEPS with UHPLC-MS/MS for the simultaneous determination of 8-isoprostaglandin F
Identifiants
pubmed: 32366899
doi: 10.1038/s41598-020-64112-2
pii: 10.1038/s41598-020-64112-2
pmc: PMC7198483
doi:
Substances chimiques
Biomarkers
0
8-epi-prostaglandin F2alpha
27415-26-5
Lactic Acid
33X04XA5AT
Dinoprost
B7IN85G1HY
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
7441Références
Ponikowski, P. et al. 2016 Esc guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC): Developed with the special contribution. Russ. J. Cardiol. 37, 2129–2200, https://doi.org/10.15829/1560-4071-2017-1-7-81 (2016).
doi: 10.15829/1560-4071-2017-1-7-81
Benjamin, E. J. et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation 139, e56–e528, https://doi.org/10.1161/CIR.0000000000000659 (2019).
doi: 10.1161/CIR.0000000000000659
pubmed: 30700139
Roger, V. L. The heart failure epidemic. Int. J. Environ. Res. Public Health 7, 1807–1830, https://doi.org/10.3390/ijerph7041807 (2010).
doi: 10.3390/ijerph7041807
pubmed: 20617060
pmcid: 2872337
Fonarow, G. C. Epidemiology and risk stratification in acute heart failure. Am. Heart J. 155, 200–2017, https://doi.org/10.1016/j.ahj.2006.10.043 (2008).
doi: 10.1016/j.ahj.2006.10.043
pubmed: 18215587
Kilgore, M., Patel, H. K., Kielhorn, A., Maya, J. F. & Sharma, P. Economic burden of hospitalizations of Medicare beneficiaries with heart failure. Risk Manag. Healthc. Policy 10, 63–70, https://doi.org/10.2147/RMHP.S130341 (2017).
doi: 10.2147/RMHP.S130341
pubmed: 28546776
pmcid: 5436769
Liao, L., Allen, L. A. & Whellan, D. J. Economic burden of heart failure in the elderly. Pharmacoeconomics 26, 447–462, https://doi.org/10.2165/00019053-200826060-00001 (2008).
doi: 10.2165/00019053-200826060-00001
pubmed: 18489197
Bredy, C. et al. New York Heart Association (NYHA) classification in adults with congenital heart disease: Relation to objective measures of exercise and outcome. Eur. Hear. J. - Qual. Care Clin. Outcomes 4, 51–58, https://doi.org/10.1093/ehjqcco/qcx031 (2018).
doi: 10.1093/ehjqcco/qcx031
Bui, A. L., Horwich, T. B. & Fonarow, G. C. Epidemiology and risk profile of heart failure. Nat. Rev. Cardiol. 8, 30–41, https://doi.org/10.1038/nrcardio.2010.165 (2011).
doi: 10.1038/nrcardio.2010.165
pubmed: 21060326
Bleumink, G. S. et al. Quantifying the heart failure epidemic: Prevalence, incidence rate, lifetime risk and prognosis of heart failure - The Rotterdam Study. Eur. Heart J. 25, 1614–1619, https://doi.org/10.1016/j.ehj.2004.06.038 (2004).
doi: 10.1016/j.ehj.2004.06.038
pubmed: 15351160
Jackson, G., Gibbs, C. R., Davies, M. K. & Lip, G. Y. ABC of heart failure. Pathophysiology. BMJ 320, 167–170, https://doi.org/10.1136/bmj.320.7228.167 (2000).
doi: 10.1136/bmj.320.7228.167
pubmed: 10634740
Fraser, R. et al. Cortisol effects on body mass, blood pressure, and cholesterol in the general population. Hypertension 33, 1364–1368, https://doi.org/10.1161/01.HYP.33.6.1364 (1999).
doi: 10.1161/01.HYP.33.6.1364
pubmed: 10373217
Watson, A. M. D., Hood, S. G. & May, C. N. Mechanisms of sympathetic activation in heart failure. Clin. Exp. Pharmacol Physiol. 33, 1269–1274, https://doi.org/10.1111/j.1440-1681.2006.04523.x (2006).
doi: 10.1111/j.1440-1681.2006.04523.x
pubmed: 17184514
Nater, U. M. & Rohleder, N. Salivary alpha-amylase as a non-invasive biomarker for the sympathetic nervous system: Current state of research. Psychoneuroendocrinology 34, 486–496, https://doi.org/10.1016/j.psyneuen.2009.01.014 (2009).
doi: 10.1016/j.psyneuen.2009.01.014
pubmed: 19249160
Adamo, L., Nassif, M. E., Novak, E., LaRue, S. J. & Mann, D. L. Prevalence of lactic acidaemia in patients with advanced heart failure and depressed cardiac output. Eur. J. Heart Fail. 19, 1027–1033, https://doi.org/10.1002/ejhf.628 (2017).
doi: 10.1002/ejhf.628
pubmed: 27647751
Chen, Q. M., Morrissy, S. & Alpert, J. S. Oxidative Stress and Heart Failure. In Comprehensive Toxicology: Third Edition, https://doi.org/10.1016/B978-0-12-801238-3.65249-2 (2017).
Krishnan, E. Hyperuricemia and incident heart failure. Circ. Hear. Fail 2, 556–562, https://doi.org/10.1161/CIRCHEARTFAILURE.108.797662 (2009).
doi: 10.1161/CIRCHEARTFAILURE.108.797662
Shirazi, L. F., Bissett, J., Romeo, F. & Mehta, J. L. Role of Inflammation in Heart Failure. Curr. Atheroscler. Rep. 19, 27, https://doi.org/10.1007/s11883-017-0660-3 (2017).
doi: 10.1007/s11883-017-0660-3
pubmed: 28432635
Andersen, L. W. et al. Etiology and therapeutic approach to elevated lactate levels. Mayo Clin. Proc. 88, 1127–1140, https://doi.org/10.1016/j.mayocp.2013.06.012 (2013).
doi: 10.1016/j.mayocp.2013.06.012
pubmed: 24079682
pmcid: 3975915
Nolan, J. P. et al. Post-cardiac arrest syndrome: Epidemiology, pathophysiology, treatment, and prognostication: A Scientific Statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Council on Stroke. Resuscutation 79, 350–379, https://doi.org/10.1016/j.ienj.2009.07.001 (2010).
doi: 10.1016/j.ienj.2009.07.001
Belch, J. J. F., Bridges, A. B., Scott, N. & Chopra, M. Oxygen free radicals and congestive heart failure. Br. Heart J 65, 245–248 (1991).
doi: 10.1136/hrt.65.5.245
Hill, M. F. & Singal, P. K. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 96, 2414–2420, https://doi.org/10.1161/01.CIR.96.7.2414 (1997).
doi: 10.1161/01.CIR.96.7.2414
pubmed: 9337218
Ide, T. et al. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ. Res. 85, 357–363, https://doi.org/10.1161/01.RES.85.4.357 (1999).
doi: 10.1161/01.RES.85.4.357
pubmed: 10455064
Sawyer, D. B. et al. Role of oxidative stress in myocardial hypertrophy and failure. J. Mol. Cell. Cardiol. 34, 379–388, https://doi.org/10.1006/jmcc.2002.1526 (2002).
doi: 10.1006/jmcc.2002.1526
pubmed: 11991728
Cesselli, D. et al. Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ. Res. 89, 279–286, https://doi.org/10.1161/hh1501.094115 (2001).
doi: 10.1161/hh1501.094115
pubmed: 11485979
Cristina Polidori, M. et al. Increased F2 isoprostane plasma levels in patients with congestive heart failure are correlated with antioxidant status and disease severity. J. Card. Fail. 10, 334–338, https://doi.org/10.1016/j.cardfail.2003.11.004 (2004).
doi: 10.1016/j.cardfail.2003.11.004
pubmed: 15309701
Muiesan, M. L., Agabiti-Rosei, C., Paini, A. & Salvetti, M. Uric acid and cardiovascular disease: An update. Eur. Cardiol 11, 54–59, https://doi.org/10.15420/ecr.2016:4:2 (2016).
doi: 10.15420/ecr.2016:4:2
pubmed: 30310447
pmcid: 6159425
Kaufman, M. & Guglin, M. Uric acid in heart failure: A biomarker or therapeutic target? Heart Fail. Rev. 18, 177–186, https://doi.org/10.1007/s10741-012-9322-2 (2013).
doi: 10.1007/s10741-012-9322-2
pubmed: 22584465
Feldman, A. M. et al. The role of tumor necrosis factor in the pathophysiology of heart failure. J. Am. Coll. Cardiol. 35, 537–544, https://doi.org/10.1016/S0735-1097(99)00600-2 (2000).
doi: 10.1016/S0735-1097(99)00600-2
pubmed: 10716453
Awad, A. E. et al. Tumor necrosis factor induces matrix metalloproteinases in cardiomyocytes and cardiofibroblasts differentially via superoxide production in a PI3Kγ-dependent manner. Am. J. Physiol. - Cell Physiol. 298, C679–C692, https://doi.org/10.1152/ajpcell.00351.2009 (2010).
doi: 10.1152/ajpcell.00351.2009
pubmed: 20007453
Onor, M. et al. Potentiometric sensor for non invasive lactate determination in human sweat. Anal. Chim. Acta 989, 80–87, https://doi.org/10.1016/j.aca.2017.07.050 (2017).
doi: 10.1016/j.aca.2017.07.050
pubmed: 28915945
Bellagambi, F. G. et al. Determination of salivary α-amylase and cortisol in psoriatic subjects undergoing the Trier Social Stress Test. Microchem. J. 136, 177–184, https://doi.org/10.1016/j.microc.2017.04.033 (2018).
doi: 10.1016/j.microc.2017.04.033
Biagini, D. et al. Determination of volatile organic compounds in exhaled breath of heart failure patients by needle trap micro-extraction coupled with gas chromatography-tandem mass spectrometry. J. Breath Res. 11, 177–184, https://doi.org/10.1088/1752-7163/aa94e7 (2017).
doi: 10.1088/1752-7163/aa94e7
Salvo, P. et al. Temperature-and pH-sensitive wearable materials for monitoring foot ulcers. Int. J. Nanomedicine 12, 949–954, https://doi.org/10.2147/ijn.S121726 (2017).
doi: 10.2147/ijn.S121726
pubmed: 28203074
pmcid: 5293368
Lomonaco, T. et al. Monitoring of warfarin therapy: Preliminary results from a longitudinal pilot study. Microchem. J. 136, 170–176, https://doi.org/10.1016/j.microc.2017.02.010 (2018).
doi: 10.1016/j.microc.2017.02.010
Lomonaco, T. et al. Influence of sampling on the determination of warfarin and warfarin alcohols in oral fluid. Plos One 9, 1–23, https://doi.org/10.1371/journal.pone.0114430 (2014).
doi: 10.1371/journal.pone.0114430
Lomonaco, T. et al. The effect of sampling procedures on the urate and lactate concentration in oral fluid. Microchem. J. 136, 255–262, https://doi.org/10.1016/j.microc.2017.02.032 (2018).
doi: 10.1016/j.microc.2017.02.032
Navazesh, M. Methods for Collecting Saliva. Ann. N. Y. Acad. Sci 20, 72–77, https://doi.org/10.1111/j.1749-6632.1993.tb18343.x (1993).
doi: 10.1111/j.1749-6632.1993.tb18343.x
Humphrey, S. P. & Williamson, R. T. A review of saliva: Normal composition, flow, and function. J. Prosthet. Dent. 85, 162–169, https://doi.org/10.1067/mpr.2001.113778 (2001).
doi: 10.1067/mpr.2001.113778
pubmed: 11208206
Tripoliti, E. E. et al. KardiaTool: An Integrated POC Solution for Non-invasive Diagnosis and Therapy Monitoring of Heart Failure Patients. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2018, 3878–3881, https://doi.org/10.1109/EMBC.2018.8513298 (2018).
doi: 10.1109/EMBC.2018.8513298
pubmed: 30441209
Bellagambi, F. G. et al. Electrochemical biosensor platform for TNF-α cytokines detection in both artificial and human saliva: Heart failure. Sens. Actuator B Chem 251, 1026–1033, https://doi.org/10.1016/j.snb.2017.05.169 (2017).
doi: 10.1016/j.snb.2017.05.169
Barhoumi, L. et al. A novel chronoamperometric immunosensor for rapid detection of TNF-Α in human saliva. Sens. Actuator B Chem 266, 477–484, https://doi.org/10.1016/j.snb.2018.03.135 (2018).
doi: 10.1016/j.snb.2018.03.135
Clark, K. D., Zhang, C. & Anderson, J. L. Sample preparation for bioanalytical and pharmaceutical analysis. Anal. Chem. 88, 11262–11270, https://doi.org/10.1021/acs.analchem.6b02935 (2016).
doi: 10.1021/acs.analchem.6b02935
pubmed: 27779849
Abdel-Rehim, M. Microextraction by packed sorbent (MEPS): A tutorial. Anal. Chim. Acta 701, 119–128, https://doi.org/10.1016/j.aca.2011.05.037 (2011).
doi: 10.1016/j.aca.2011.05.037
pubmed: 21801877
Garde, A. H. & Hansen, Å. M. Long-term stability of salivary cortisol. Scand. J. Clin. Lab. Invest. 65, 433–436, https://doi.org/10.1080/00365510510025773 (2005).
doi: 10.1080/00365510510025773
pubmed: 16081365
Zamora, E. et al. Estimated glomerular filtration rate and prognosis in heart failure: Value of the modification of diet in Renal Disease Study-4, chronic kidney disease epidemiology collaboration, and Cockroft-Gault formulas. J. Am. Coll. Cardiol. 59, 1709–1715, https://doi.org/10.1016/j.jacc.2011.11.066 (2012).
doi: 10.1016/j.jacc.2011.11.066
pubmed: 22554602
Paulus, W. J. et al. How to diagnose diastolic heart failure: A consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur. Heart J. 28, 2539–2550, https://doi.org/10.1093/eurheartj/ehm037 (2007).
doi: 10.1093/eurheartj/ehm037
pubmed: 17428822
Haque, W. A. et al. Hemodynamic effects of supplemental oxygen administration in congestive heart failure. J. Am. Coll. Cardiol. 27, 353–357, https://doi.org/10.1016/0735-1097(95)00474-2 (1996).
doi: 10.1016/0735-1097(95)00474-2
pubmed: 8557905
Montuschi, P. & Barnes, P. J. Analysis of exhaled breath condensate for monitoring airway inflammation. Trends Pharmacol. Sci. 23, 232–7, https://doi.org/10.1016/s0165-6147(02)02020-5 (2002).
doi: 10.1016/s0165-6147(02)02020-5
pubmed: 12008001
Kitano, S., Hisatomi, H., Hibi, N., Kawano, K. & Harada, S. Improved method of plasma 8-Isoprostane measurement and association analyses with habitual drinking and smoking. World J. Gastroenterol. 12, 5846–5852, https://doi.org/10.3748/wjg.v12.i36.5846 (2006).
doi: 10.3748/wjg.v12.i36.5846
pubmed: 17007051
pmcid: 4100666
Smith, K. A., Shepherd, J., Wakil, A. & Kilpatrick, E. S. A comparison of methods for the measurement of 8-isoPGF(2α): A marker of oxidative stress. Ann. Clin. Biochem. 48, 147–154, https://doi.org/10.1258/acb.2010.010151 (2011).
doi: 10.1258/acb.2010.010151
pubmed: 21292864
Janicka, M. et al. LC-MS/MS determination of isoprostanes in plasma samples collected from mice exposed to doxorubicin or tert-butyl hydroperoxide. Int. J. Mol. Sci. 14, 6157–6169, https://doi.org/10.3390/ijms14036157 (2013).
doi: 10.3390/ijms14036157
pubmed: 23507752
pmcid: 3634494
Lee, C. Y. J., Jenner, A. M. & Halliwell, B. Rapid preparation of human urine and plasma samples for analysis of F 2-isoprostanes by gas chromatography-mass spectrometry. Biochem. Biophys. Res. Commun. 320, 696–702, https://doi.org/10.1016/j.bbrc.2004.06.015 (2004).
doi: 10.1016/j.bbrc.2004.06.015
pubmed: 15240104
Milne, G. L., Gao, B., Terry, E. S., Zackert, W. E. & Sanchez, S. C. Measurement of F2- isoprostanes and isofurans using gas chromatography-mass spectrometry. Free Radic. Biol. Med. 59, 36–44, https://doi.org/10.1016/j.freeradbiomed.2012.09.030 (2013).
doi: 10.1016/j.freeradbiomed.2012.09.030
pubmed: 23044261
Saracino, M. A. et al. Multi-matrix assay of cortisol, cortisone and corticosterone using a combined MEPS-HPLC procedure. J. Pharm. Biomed. Anal. 88, 643–648, https://doi.org/10.1016/j.jpba.2013.10.008 (2014).
doi: 10.1016/j.jpba.2013.10.008
pubmed: 24231793
Seino, Y. et al. Application of NT-proBNP and BNP measurements in cardiac care: A more discerning marker for the detection and evaluation of heart failure. Eur. J. Heart Fail. 6, 295–300, https://doi.org/10.1016/j.ejheart.2003.12.009 (2004).
doi: 10.1016/j.ejheart.2003.12.009
pubmed: 14987579
Panagopoulou, V. et al. NTproBNP: An Important Biomarker in Cardiac Diseases. Curr. Top. Med. Chem. 13, 82–94, https://doi.org/10.2174/1568026611313020002 (2013).
doi: 10.2174/1568026611313020002
pubmed: 23470072
Kemp, C. D. & Conte, J. V. The pathophysiology of heart failure. Cardiovas. Pathol 21, 365–371, https://doi.org/10.1016/j.carpath.2011.11.007 (2012).
doi: 10.1016/j.carpath.2011.11.007
Ogawa, T. & de Bold, A. J. Natriuretic peptides. in Natriuretic Peptides: Physiology, Molecular Biology, and Clinical Implications (2014).
Lazzeri, C., Valente, S., Chiostri, M. & Gensini, G. F. Clinical significance of Lactate in acute cardiac patients. World J. Cardiol. 7, 483–489, https://doi.org/10.4330/wjc.v7.i8.48 (2015).
doi: 10.4330/wjc.v7.i8.48
pubmed: 26322188
pmcid: 4549782
Emerit, J., Edeas, M. & Bricaire, F. Neurodegenerative diseases and oxidative stress. Biomed. Pharmacother. 58, 39–46, https://doi.org/10.1016/j.biopha.2003.11.004 (2004).
doi: 10.1016/j.biopha.2003.11.004
pubmed: 14739060
Leung, K. S., Galano, J. M., Durand, T. & Lee, J. C. Y. Current development in non-enzymatic lipid peroxidation products, isoprostanoids and isofuranoids, in novel biological samples. Free Radic. Res. 49, 816–826, https://doi.org/10.3109/10715762.2014.960867 (2015).
doi: 10.3109/10715762.2014.960867
pubmed: 25184341
Biagini, D. et al. Micro-extraction by packed sorbent combined with UHPLC-ESI-MS/MS for the determination of prostanoids and isoprostanoids in dried blood spots. Talanta, https://doi.org/10.1016/j.talanta.2019.120236 (2020).
Chicharro, J. L., Lucía, A., Pérez, M., Vaquero, A. F. & Ureña, R. Saliva composition and exercise. Sports Med. 26, 17–27, https://doi.org/10.2165/00007256-199826010-00002 (1998).
doi: 10.2165/00007256-199826010-00002
pubmed: 9739538